Qiu‐Xu Teng

VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters

Ning Ji, Yuqi Yang, Chao‐Yun Cai et al. · Frontiers in Pharmacology · 2018 · 74 citations · Full text

Medicine, Oncology, Pharmacology +17

Tepotinib reverses ABCB1-mediated multidrug resistance in cancer cells

Zhuo‐Xun Wu, Qiu‐Xu Teng, Chao‐Yun Cai et al. · Biochemical Pharmacology · 2019 · 70 citations

Medicine, Oncology, Pharmacology +14

Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells

Wei Zhang, Yingfang Fan, Chao‐Yun Cai et al. · Frontiers in Pharmacology · 2018 · 59 citations · Full text

Medicine, Oncology, Pharmacology +16

Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo

Albert A. De Vera, Pranav Gupta, Zi‐Ning Lei et al. · Cancer Letters · 2018 · 58 citations · Full text

Medicine, Oncology, Pharmacology +12

Venetoclax, a BCL-2 Inhibitor, Enhances the Efficacy of Chemotherapeutic Agents in Wild-Type ABCG2-Overexpression-Mediated MDR Cancer Cells

Jing‐Quan Wang, Jonathan Y. Li, Qiu‐Xu Teng et al. · Cancers · 2020 · 53 citations · Full text

Medicine, Oncology, Pharmacology +17